Broadly impaired NK cell function in non-obese diabetic mice is partially restored by NK cell activation in vivo and by IL-12/IL-18 in vitro

International Immunology

Volumn 16, Issue 1, 2004, Pages 1-11

  Johansson, Sofia E ^a   Hall, Håkan ^a   Björklund, Jens ^a   Höglund, Petter ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Activation; Cytokine; Cytotoxicity; Diabetes; NK cell

Indexed keywords

ALPHA INTERFERON; BETA 2 MICROGLOBULIN; BETA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TILORONE;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL POPULATION; CONTROLLED STUDY; DIABETES MELLITUS; GENE MUTATION; IN VITRO STUDY; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR CELL;

ANIMALS; BETA 2-MICROGLOBULIN; CYTOTOXICITY, IMMUNOLOGIC; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; INTERLEUKIN-12; INTERLEUKIN-18; KILLER CELLS, NATURAL; MICE; MICE, INBRED NOD;

EID: 0347989293     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh002     Document Type: Article

References (65)

1. Yokoyama, W. M. 1999. Natural killer cells. In Paul, W. E., ed., Fundamental Immunology, 4th edn, p. 575. Lippincott-Raven, Philadelphia, PA.
2. Kos, F. J. 1998. Regulation of adaptive immunity by natural killer cells. Immunol. Res. 17:303.
3. Kelly, J. M., Takeda, K., Darcy, P. K., Yagita, H. and Smyth, M. J. 2002. A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo. J. Immunol. 168:4472.
4. Flodström, M., Maday, A., Balakrishna, D., Cleary, M. M., Yoshimura, A. and Sarvetnick, N. 2002. Target cell defense prevents the development of diabetes after viral infection. Nat. Immunol. 3:373.
5. Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M. and Tabira, T. 1997. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186:1677.
6. McQueen, K. L. and Parham, P. 2002. Variable receptors controlling activation and inhibition of NK cells. Curr. Opin. Immunol. 14:615.
7. Kärre, K., Ljunggren, H.-G., Piontek, G. and Kiessling, R. 1986. Selective rejection of H-2-deficient lymphoma variant suggest alternative immune defence strategy. Nature 319:675.
8. Lunggren, H.-G. and Kärre, K. 1990. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11:237.
9. Colucci, F., Di Santo, J. P. and Leibson, P. J. 2002. Natural killer cell activation in mice and men: different triggers for similar weapons? Nat. Immunol. 3:807.
10. Jiang, K., Zhong, B., Gilvary, D. L., Corliss, B. C., Hong-Geller, E., Wei, S. and Djeu, J. Y. 2000. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat. Immunol. 1:419.
11. Wu, J., Song, Y., Bakker, A. B., Bauer, S., Spies, T., Lanier, L. L. and Phillips, J. H. 1999. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285:730.
12. Bonnema, J. D., Karnitz, L. M., Schoon, R. A., Abraham, R. T. and Leibson, P. J. 1994. Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. J. Exp. Med. 180:1427.
13. Perussia, B. 2000. Signaling for cytotoxicity. Nat. Immunol. 1:372.
14. Smith, K. M., Wu, J., Bakker, A. B., Phillips, J. H. and Lanier, L. L. 1998. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161:7.
15. Tomasello, E., Desmoulins, P. O., Chemin, K., Guia, S., Cremer, H., Ortaldo, J., Love, P., Kaiserlian, D. and Vivier, E. 2000. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity 13:355.
16. Lanier, L. L., Corliss, B. C., Wu, J., Leong, C. and Phillips, J. H. 1998. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391:703.
17. Lanier, L. L., Corliss, B., Wu, J. and Phillips, J. H. 1998. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 8:693.
18. Mason, L. H., Anderson, S. K., Yokoyama, W. M., Smith, H. R., Winkler-Pickett, R. and Ortaldo, J. R. 1996. The Ly-49D receptor activates murine natural killer cells. J. Exp. Med. 184:2119.
19. Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N. and Raulet, D. H. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1: 119.
20. Djeu, J. Y., Jiang, K. and Wei, S. 2002. A view to a kill: signals triggering cytotoxicity. Clin. Cancer Res. 8:636.
21. Chuang, S. S., Kim, M. H., Johnson, L. A., Albertsson, P., Kitson, R. P., Nannmark, U., Goldfarb, R. H. and Mathew, P. A. 2000. 2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness. Immunology 100:378.
22. Ogasawara, K., Yoshinaga, S. K. and Lanier, L. L. 2002. Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells, J. Immunol. 169;3676.
23. Colucci, F., Schweighoffer, E., Tomasello, E., Turner, M., Ortaldo, J. R., Vivier, E., Tybulewicz, V. L. and Di Santo, J. P. 2002. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat. Immunol. 3:288.
24. Jamieson, A. M., Diefenbach, A., McMahon, C. W., Xiong, N., Carlyle, J. R. and Raulet, D. H. 2002. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17:19.
25. Shi, F. D., Wang, H. B., Li, H., Hong, S., Taniguchi, M., Link, H., Van Kaer, L. and Ljunggren, H. G. 2000. Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat. Immunol. 1:245.
26. Matsumoto, Y., Kohyama, K., Aikawa, Y., Shin, T., Kawazoe, Y., Suzuki, Y. and Tanuma, N. 1998. Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis. Eur. J. Immunol. 28:1681.
27. + T cells in a transfer model of colitis. J. Immunol. 161:3256.
28. Adorini, L., Gregori, S. and Harrison, L. C. 2002. Understanding autoimmune diabetes: insights from mouse models. Trends Immunol. 8:31.
29. Kataoka, S., Satoh, J., Fujiya, H., Toyota, T., Suzuki, R., Itoh, K. and Kumagai, K. 1983. Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes 32:247.
30. Poulton, L. D., Smyth, M. J., Hawke, C. G., Silveira, P., Shepherd, D., Naidenko, O. V., Godfrey, D. I. and Baxter, A. G. 2001. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int. Immunol. 13:887.
31. Carnaud, C., Gombert, J., Donnars, O., Garchon, H. and Herbelin, A. 2001. Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex. J. Immunol. 166:2404.
32. Shultz, L. D., Schweitzer, P. A., Christianson, S. W., Gott, B., Schweitzer, I. B., Tennent, B., McKenna, S., Mobraaten, L., Rajan, T. V., Greiner, D. L., et al. 1995. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 154:180.
33. Ogasawara, K., Hamerman, J. A., Hsin, H., Chikuma, S., Bour-Jordan, H., Chen, T., Pertel, T., Carnaud, C., Bluestone, J. A. and Lanier, L. L. 2003. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18:41.
34. Arase, H., Saito, T., Phillips, J. H. and Lanier, L. L. 2001. Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J. Immunol. 167:1141.
35. Tanaka, T., Tsudo, M., Karasuyama, H., Kitamura, F., Kono, T., Hatakeyama, M., Taniguchi, T. and Miyasaka, M. 1991. A novel monoclonal antibody against murine IL-2 receptor beta-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells. J. Immunol. 147:2222.
36. Wicker, L. S., Todd, J. A. and Peterson, L. B. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179.
37. Vyse, T. J. and Todd, J. A. 1996. Genetic analysis of autoimmune disease. Cell 85:311.
38. Gidlund, M., Orn, A., Wigzell, H., Senik, A. and Gresser, I. 1978. Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273:759.
39. Kim, S., Iizuka, K., Kang, H.-S. P., Dokun, A., French, A. R., Greco, S. and Yokoyama, W. M. 2002. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3:523.
40. Idris, A. H., Smith, H. R., Mason, L. H., Ortaldo, J. R., Scalzo, A. A. and Yokoyama, W. M. 1999. The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing. Proc. Natl Acad. Sci. USA 96:6330.
41. Idris, A. H., Iizuka, K., Smith, H. R., Scalzo, A. A. and Yokoyama, W. M. 1998. Genetic control of natural killing and in vivo tumor elimination by the Chok locus. J. Exp. Med. 188:2243.
42. Nakamura, M. C., Naper, C., Niemi, E. C., Spusta, S. C., Rolstad, B., Butcher, G. W., Seaman, W. E. and Ryan, J. C. 1999. Natural killing of xenogeneic cells mediated by the mouse Ly-49D receptor. J. Immunol. 163:4694.
43. - bone marrow in chimeric mice. Proc. Natl Acad. Sci. USA 88:10332.
44. Liao, N. S., Bix, M., Zijlstra, M., Jaenisch, R. and Raulet, D. 1991. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253:199.
45. Lyons, A. B. and Parish, C. R. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171:131.
46. Oehen, S., Brduscha-Riem, K., Oxenius, A. and Odermatt, B. 1997. A simple method for evaluating the rejection of grafted spleen cells by flow cytometry and tracing adoptively transferred cells by light microscopy. J. Immunol. Methods 207:33.
47. Höglund, P., Glas, R., Öhlën, C., Ljunggren, H. G. and Kärre, K. 1991. Alteration of the natural killer repertoire in H-2 transgenic mice: specificity of rapid lymphoma cell clearance determined by the H-2 phenotype of the target. J. Exp. Med. 174:327.
48. Lauwerys, B. R., Renauld, J.-C. and Houssiau, F. A. 1999. Synergistic proliferation and activation of Natural Killer cells by interleukin 12 and interleukin 18. Cytokine 11:822.
49. McVicar, D. W., Winkler-Pickett, R., Taylor, L. S., Makrigiannis, A., Bennett, M., Anderson, S. K. and Ortaldo, J. R. 2002. Aberrant DAP12 signaling in the 129 strain of mice: implications for the analysis of gene-targeted mice. J. Immunol. 169:1721.
50. Bakker, A. B., Hoek, R. M., Cerwenka, A., Blom, B., Lucian, L., McNeil, T., Murray, R., Phillips, L. H., Sedgwick, J. D. and Lanier, L. L. 2000. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13:345.
51. Lowin-Kropf, B., Kunz, B., Schneider, P. and Held, W. 2002. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors. Eur. J. Immunol. 32:773.
52. Chan, G., Hanke, T. and Fischer, K. D. 2001. Vav-1 regulates NK T cell development and NK cell cytotoxicity. Eur. J. Immunol. 31:2403.
53. Diefenbach, A., Tomasello, E., Lucas, M., Jamieson, A. M., Hsia, J. K., Vivier, E. and Raulet, D. H. 2002. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol. 3:1142.
54. Gilfillan, S., Ho, E. L., Cella, M., Yokoyama, W. M. and Colonna, M. 2002. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat Immunol. 3:1150.
55. Lowin-Kropf, B., Kunz, B., Beermann, F. and Held, W. 2002. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1. J Immunol. 165:1314.
56. Lowin-Kropf, B. and Held, W. 2000. Positive impact of inhibitory Ly49 receptor-MHC class I interaction on NK cell development. J. Immunol. 165:91.
57. Tsutsui, H., Nakanishi, K., Matsui, K., Higashino, K., Okamura, H., Miyazawa, Y., Kaneda, K. 1996. IFN-gamma-inducing factor upregulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 157:3967.
58. Hashimoto, W., Osaki, T., Okamura, H., Robbins, P. D., Kurimoto, M., Nagata, S., Lotze, M. T. and Tahara, H. 1999. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis respectively. J. Immunol. 163:583.
59. Screpanti. V., Wallin, R. P., Ljunggren, H.-G. and Grandien, A. 2001. A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells. J. Immunol. 167:2068.
60. Sato, K., Hida, S., Takayanagi, H., Yokochi, T., Nobuhiko, K., Takeda, K., Yagita, H., Okomura, K., Tanaka, N., Taniguchi, T. and Ogasawara, K. 2001. Antiviral response by natural killer cells through TRAIL gene induction by IFA-α/β. Eur. J. Immunol. 31:3138.
61. Algarra, I., Perez, M., Hoglund, P., Gaforio, J. J., Ljunggren, H. G. and Garrido, F 1993. Generation and control of metastasis in experimental tumor systems; inhibition of experimental metastases by a tilorone analogue. Int. J. Cancer 54:518.
62. Afifi, M. S., Kumar, V. and Bennett, M. 1985. Stimulation of genetic resistance to marrow grafts in mice by interferon-alpha/beta. J. Immunol. 134:3739.
63. Yu, Y. Y., Kumar, V. and Bennett, M. 1992. Murine natural killer cells and marrow graft rejection. Annu. Rev. Immunol. 10:189.
64. Serreze, D. V., Hamaguchi, K. and Leiter, E. H. 1989. Immunostimulation circumvents diabetes in NOD/Lt mice. J. Autoimmun. 2:759.
65. h1-dependent destructive imsulitis. J. Immunol. 163:1230.